Appili Therapeutics Inc Class A's market cap is currently ―. The company's EPS TTM is $-0.032; its P/E ratio is -0.89; Appili Therapeutics Inc Class A is scheduled to report earnings on June 26, 2024, and the estimated EPS forecast is

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	C$ 478.40K	C$ 337.31K	-	C$ 334.18K	-
Gross Profit	C$ 478.40K	C$ 337.31K	-	C$ 334.18K	-
EBIT	C$ 292.38K	C$ -506.34K	C$ -1.15M	C$ -2.16M	C$ -2.31M
EBITDA	C$ 292.38K	C$ -502.90K	C$ -1.15M	C$ -2.16M	C$ -2.31M
Net Income Common Stockholders	C$ -152.34K	C$ -976.55K	C$ -1.55M	C$ -2.62M	C$ -2.62M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 602.88K	C$ 395.62K	C$ 520.59K	C$ 2.47M	C$ 1.43M
Total Assets	C$ 1.97M	C$ 1.96M	C$ 2.17M	C$ 3.13M	C$ 3.17M
Total Debt	C$ 8.01M	C$ 8.00M	C$ 7.69M	C$ 7.67M	C$ 5.44M
Net Debt	C$ 7.41M	C$ 7.61M	C$ 7.17M	C$ 5.20M	C$ 4.01M
Total Liabilities	C$ 11.80M	C$ 11.65M	C$ 10.94M	C$ 10.53M	C$ 7.94M
Stockholders Equity	C$ -9.83M	C$ -9.70M	C$ -8.77M	C$ -7.40M	C$ -5.36M
Cash Flow	-
Free Cash Flow	-	-	C$ -2.05M	C$ -1.12M	C$ -957.30K
Operating Cash Flow	-	C$ -237.14K	C$ -2.02M	C$ -1.11M	C$ -957.30K
Investing Cash Flow	-	-	C$ -29.72K	C$ -6.67K	-
Financing Cash Flow	-	C$ 111.72K	C$ 107.58K	C$ 2.16M	C$ -42.24K

Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Income Statement >

Appili Therapeutics Inc Class A Debt to Assets

Balance Sheet >

Appili Therapeutics Inc Class A Cash Flow

Cash Flow >

Appili Therapeutics Inc Class A Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing